Stay updated on IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedA new revision label 'Revision: v3.6.5' appears in the history, while the previous 'Revision: v3.6.4' entry is removed, reflecting a backend update to the page's version history.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe study record history adds a new revision entry for version v3.6.4, replacing v3.6.3 and indicating an updated record version.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe latest history entry is updated to Revision: v3.6.3, replacing the previous v3.6.2. This is an administrative update to the history list and does not modify study data or user-facing content.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry 'Revision: v3.6.2' was added to the study record history, and the older entry 'Revision: v3.6.0' was removed. This updates the history to reflect the latest revision labeling for the record.SummaryDifference0.1%

- Check62 days agoChange DetectedRecruitment status updated to no longer look for participants, signaling enrollment closure. A new revision tag v3.6.0 was added and the previous tag v3.5.5 was removed.SummaryDifference0.4%

- Check69 days agoChange DetectedA new revision entry 'Revision: v3.5.5' is added to the study record history, replacing the previous 'Revision: v3.5.4'. This reflects an updated revision of the ClinicalTrials.gov page history.SummaryDifference0.1%

Stay in the know with updates to IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.